|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication August 31, 2005.
Revised November 8, 2005.
Accepted for publication November 8, 2005.
Activated Pro-drug Causes Kinase Activation Concurrent with S-glutathionylation of Proteins
Nitric oxide (NO) is an endogenous, diffusible, trans-cellular messenger shown to impact regulatory and signaling pathways with impact on cell survival. Exposure to NO can impart direct post-translational modifications on target proteins such as nitration and/or nitrosylation. Alternatively, after interaction with oxygen, superoxide, glutathione or certain metals NO can lead to S-glutathionylation, a post-translational modification potentially critical to signaling pathways. A novel GST
activated pro-drug, O2-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl} 1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate or PABA/NO liberates NO and elicits toxicity in vitro and in vivo. We now show that PABA/NO induces nitrosative stress resulting in undetectable nitrosylation, limited nitration and high levels of S-glutathionylation. After a single pharmacologically relevant dose of PABA/NO, S-glutathionylation occurs rapidly (<5 mins) and is sustained for ~ 7h, implying a half-life for the deglutathionylation process of approximately 3h. 2D SDS-PAGE and immunoblotting with a monoclonal antibody to S-glutathionylated residues indicated that numerous proteins were S-glutathionylated. Subsequent MALDI-TOF analysis identified 10 proteins, including
-lactate dehydrogenase, Rho GDP dissociation inhibitor
, ATP synthase, elongation factor 2, protein disulfide isomerase, nucleophosmin-1, chaperonin, actin, PTP1B and glucosidase II. In addition, we showed that sustained S-glutathionylation was temporally concurrent with drug-induced activation of the stress kinases, known to be linked with cell death pathways. This is consistent with the fact that PABA/NO induces S-glutathionylation and inactivation of PTP1B, one phosphatase that can participate in deactivation of kinases. These effects were consistent with the presence of intracellular PABA/NO or metabolites, since MRP1 over-expressing cells were less sensitive to the drug and had reduced levels of S-glutathionylated proteins.
Key words:
Nitric oxide, MAP Kinase, Glutathione S-transferases, Phase II enzymes, Regulation - post-transcriptional, Glutathione, Oxidative stress/antioxidants, Oxidative stress, Mechanisms of cell killing/apoptosis, Pharmacokinetics, metabolism and activation
This article has been cited by other articles:
![]() |
D. M. Townsend, Y. Manevich, L. He, Y. Xiong, R. R. Bowers Jr., S. Hutchens, and K. D. Tew Nitrosative Stress-Induced S-Glutathionylation of Protein Disulfide Isomerase Leads to Activation of the Unfolded Protein Response Cancer Res., October 1, 2009; 69(19): 7626 - 7634. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Gao, M. Bedhomme, D. Veyel, M. Zaffagnini, and S. D. Lemaire Methods for Analysis of Protein Glutathionylation and their Application to Photosynthetic Organisms Mol Plant, March 1, 2009; 2(2): 218 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Townsend, Y. Manevich, L. He, S. Hutchens, C. J. Pazoles, and K. D. Tew Novel Role for Glutathione S-Transferase {pi}: REGULATOR OF PROTEIN S-GLUTATHIONYLATION FOLLOWING OXIDATIVE AND NITROSATIVE STRESS J. Biol. Chem., January 2, 2009; 284(1): 436 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Townsend, L. He, S. Hutchens, T. E. Garrett, C. J. Pazoles, and K. D. Tew NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox Balance Cancer Res., April 15, 2008; 68(8): 2870 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Townsend S-Glutathionylation: Indicator of Cell Stress and Regulator of the Unfolded Protein Response Mol. Interv., December 1, 2007; 7(6): 313 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. West, B. G. Hill, Y.-T. Xuan, and A. Bhatnagar Protein glutathiolation by nitric oxide: an intracellular mechanism regulating redox protein modification FASEB J, August 1, 2006; 20(10): 1715 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Findlay, D. M. Townsend, T. E. Morris, J. P. Fraser, L. He, and K. D. Tew A Novel Role for Human Sulfiredoxin in the Reversal of Glutathionylation. Cancer Res., July 1, 2006; 66(13): 6800 - 6806. [Abstract] [Full Text] [PDF] |
||||